936844-18-7

Upstream product

• 355134-13-3 3-bromo-5-nitrobenzaldehyde 
• 107-21-1 ethylene glycol 
• 99-61-6 3-nitro-benzaldehyde 

Downstream Products

• 936844-19-8 3-bromo-5-(1,3-dioxolan-2-yl)aniline 
• 909854-23-5 3-bromo-5-[1,3]dioxolan-2-yl-phenol 
• 936844-24-5 2-(3-bromo-5-iodophenyl)-1,3-dioxolane 
• 936844-20-1 3-bromo-5-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}benzaldehyde 
• 936844-25-6 {[3-bromo-5-(1,3-dioxolan-2-yl)phenyl]ethynyl}(triisopropyl)silane 
• 936844-21-2 2-(3-bromo-5-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}phenyl)-1,3-dioxolane 
• 199177-26-9 3-bromo-5-hydroxybenzaldehyde 
• 1429129-61-2 3-(3,5-dimethylisoxazol-4-yl)-5-hydroxybenzaldehyde 
• 1429129-73-6 3-(3,5-dimethylisoxazol-4-yl)-5-methoxybenzaldehyde 
• 1429129-62-3 C₁₄H₁₅NO₃ 

Relevant academic research and scientific papers

Synthesis and biological evaluation of GPR40/FFAR1 agonists containing 3,5-dimethylisoxazole

GPR40 is an attractive target due to its glucose-stimulated insulin secretion effect with low risk of causing hypoglycemia, which also can be seen from the clinical studies using TAK-875 (fasiglifam). In the present studies, we discovered a series of anal

Covalent assembly of molecular ladders

[n]-Rung molecular ladders (n = 3-6) have been prepared by reacting discrete, complimentary m-phenylene ethynylene oligomers using imine formation/exchange. The nanostructures, which in the largest case measure approximately 1.6 × 6.2 nm, have been charac